Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 7 studies | 22% ± 8% | |
epithelial cell | 3 studies | 35% ± 11% | |
ciliated cell | 3 studies | 22% ± 7% |
Insufficient scRNA-seq data for expression of PDCL at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 1130.64 | 459 / 459 | 100% | 28.88 | 1118 / 1118 |
esophagus | 100% | 850.01 | 1445 / 1445 | 100% | 22.67 | 183 / 183 |
intestine | 100% | 895.51 | 966 / 966 | 100% | 21.42 | 527 / 527 |
lung | 100% | 1149.12 | 578 / 578 | 100% | 25.28 | 1155 / 1155 |
stomach | 100% | 687.54 | 359 / 359 | 100% | 20.19 | 286 / 286 |
brain | 100% | 737.69 | 2641 / 2642 | 100% | 31.45 | 705 / 705 |
prostate | 100% | 791.28 | 245 / 245 | 100% | 27.91 | 501 / 502 |
uterus | 100% | 1089.67 | 170 / 170 | 100% | 26.22 | 458 / 459 |
ovary | 100% | 719.40 | 180 / 180 | 100% | 21.94 | 429 / 430 |
thymus | 100% | 1009.11 | 653 / 653 | 100% | 22.29 | 602 / 605 |
bladder | 100% | 836.90 | 21 / 21 | 99% | 21.04 | 499 / 504 |
kidney | 100% | 615.85 | 89 / 89 | 98% | 21.31 | 887 / 901 |
skin | 100% | 1091.46 | 1809 / 1809 | 98% | 19.29 | 464 / 472 |
adrenal gland | 99% | 775.36 | 256 / 258 | 97% | 21.13 | 223 / 230 |
pancreas | 97% | 419.62 | 318 / 328 | 99% | 19.67 | 176 / 178 |
liver | 96% | 298.70 | 216 / 226 | 88% | 8.89 | 359 / 406 |
adipose | 100% | 1199.56 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 28.25 | 29 / 29 |
spleen | 100% | 1023.05 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 27.38 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.49 | 1 / 1 |
blood vessel | 100% | 1010.32 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 477.85 | 852 / 861 | 0% | 0 | 0 / 0 |
muscle | 91% | 263.90 | 733 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 91% | 12.72 | 73 / 80 |
peripheral blood | 80% | 553.87 | 740 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045880 | Biological process | positive regulation of smoothened signaling pathway |
GO_0007165 | Biological process | signal transduction |
GO_0007601 | Biological process | visual perception |
GO_0008277 | Biological process | regulation of G protein-coupled receptor signaling pathway |
GO_0030030 | Biological process | cell projection organization |
GO_1902605 | Biological process | heterotrimeric G-protein complex assembly |
GO_0005929 | Cellular component | cilium |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005515 | Molecular function | protein binding |
Gene name | PDCL |
Protein name | Phosducin like Phosducin-like protein (PHLP) |
Synonyms | PHLOP1 PhLP1 |
Description | FUNCTION: Acts as a positive regulator of hedgehog signaling and regulates ciliary function. .; FUNCTION: [Isoform 1]: Functions as a co-chaperone for CCT in the assembly of heterotrimeric G protein complexes, facilitates the assembly of both Gbeta-Ggamma and RGS-Gbeta5 heterodimers.; FUNCTION: [Isoform 2]: Acts as a negative regulator of heterotrimeric G proteins assembly by trapping the preloaded G beta subunits inside the CCT chaperonin. |
Accessions | ENST00000436632.5 H0Y3M0 Q13371 ENST00000394285.3 ENST00000259467.9 [Q13371-1] H0Y5D3 |